Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

FDA adds blood clot warning to testosterone products

Warns of risk of developing deep vein thrombosis and pulmonary embolism

- PMLiVE

Boehringer pulls faldaprevir and exits hepatitis C market

Unable to challenge all-oral options from Gilead and others

- PMLiVE

Destination Discovery – Lilly’s answer to Boehringer’s Syrum?

Lilly launches online drug discovery game

Pegasus’s Approach to Measurement Wins 3 Gold’s at 2014 AMEC International Summit in Amsterdam

Pegasus, the UK’s leading independent health communications consultancy, added three awards to its 2014 portfolio at last weekend’s AMEC International Summit 2014 in Amsterdam

Inizio

- PMLiVE

Cubist gets green light from FDA for new antibiotic Sivextro

First drug approved under qualified infectious disease product framework

- PMLiVE

UK biotech Retrogenix appoints Matthew Britiz

He takes up role as North American business development director

- PMLiVE

NHS names ‘procurement champion’

Lord Carter will have to help the health service save £2bn from its budget

Shire Basingstoke

Shire turns down takeover offer from AbbVie

Marks third time UK pharma company has turned down AbbVie's advances

- PMLiVE

Takeda drops prostate cancer drug in phase III

Suffers another late-stage pipeline blow as orteronel disappoints

- PMLiVE

Cubist antibiotic to get priority review in US

FDA will expedite assessment of ceftolozane/ tazobactam

- PMLiVE

Teva’s chair Philip Frost to step down

He will leave the Israeli pharma company by the end of the year

- PMLiVE

Allergan and taking a specialised approach

Pharma interview: Paul Navarre and Paul Boland talk about how the company, best known for Botox, is looking to create a culture of growth

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links